Kezar Life Sciences to Participate in the Cowen 43rd Annual Health Care Conference

Author's Avatar
Mar 01, 2023

Kezar+Life+Sciences%2C+Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that Noreen Roth Henig, M.D., Chief Medical Officer, will participate on the Autoimmune/Complement/Inflammation panel discussion at the Cowen 43rd Annual Health Care Conference on Tuesday, March 7, 2023 at 10:30 am ET in Boston, MA.